Floris D. de Hon

417 total citations
10 papers, 365 citations indexed

About

Floris D. de Hon is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Floris D. de Hon has authored 10 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Floris D. de Hon's work include Cytokine Signaling Pathways and Interactions (7 papers), HER2/EGFR in Cancer Research (3 papers) and NF-κB Signaling Pathways (3 papers). Floris D. de Hon is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), HER2/EGFR in Cancer Research (3 papers) and NF-κB Signaling Pathways (3 papers). Floris D. de Hon collaborates with scholars based in Netherlands, Germany and Japan. Floris D. de Hon's co-authors include Rick Hoekzema, Philip I. Murray, Aize Kijlstra, Stefan Rose‐John, Just P. J. Brakenhoff, L Aarden, Marc Ehlers, Edwin ten Boekel, Heidi Schooltink and J. Content and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and FEBS Letters.

In The Last Decade

Floris D. de Hon

10 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Floris D. de Hon Netherlands 6 154 146 107 87 76 10 365
S. Maloney Canada 12 114 0.7× 114 0.8× 343 3.2× 193 2.2× 111 1.5× 32 528
Bjoern Schuster Czechia 4 185 1.2× 206 1.4× 8 0.1× 75 0.9× 17 0.2× 9 379
Sébastien P. Gendron Canada 11 39 0.3× 28 0.2× 73 0.7× 153 1.8× 113 1.5× 13 315
Lauren Van Der Kraak Canada 9 149 1.0× 98 0.7× 29 0.3× 186 2.1× 9 0.1× 13 392
Timothy Isaacs Australia 10 59 0.4× 65 0.4× 297 2.8× 111 1.3× 85 1.1× 19 381
Rosa Lovis United States 7 74 0.5× 208 1.4× 5 0.0× 114 1.3× 68 0.9× 9 408
Mathias Krohn Germany 10 161 1.0× 32 0.2× 45 0.4× 100 1.1× 60 0.8× 20 367
Hiromichi Gomi Japan 7 83 0.5× 94 0.6× 22 0.2× 141 1.6× 12 0.2× 21 316
Vibeke Sundvold‐Gjerstad Norway 13 117 0.8× 247 1.7× 7 0.1× 272 3.1× 40 0.5× 22 506
Joseph M. Lee Canada 9 101 0.7× 56 0.4× 16 0.1× 307 3.5× 10 0.1× 11 402

Countries citing papers authored by Floris D. de Hon

Since Specialization
Citations

This map shows the geographic impact of Floris D. de Hon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floris D. de Hon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floris D. de Hon more than expected).

Fields of papers citing papers by Floris D. de Hon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Floris D. de Hon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floris D. de Hon. The network helps show where Floris D. de Hon may publish in the future.

Co-authorship network of co-authors of Floris D. de Hon

This figure shows the co-authorship network connecting the top 25 collaborators of Floris D. de Hon. A scholar is included among the top collaborators of Floris D. de Hon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Floris D. de Hon. Floris D. de Hon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hon, Floris D. de, Edwin ten Boekel, Claude Clément, et al.. (1995). Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130. Cytokine. 7(5). 398–407. 11 indexed citations
2.
Hon, Floris D. de, et al.. (1995). Development of Human IL‐6 Receptor Antagonists. Annals of the New York Academy of Sciences. 762(1). 129–135. 5 indexed citations
3.
Hon, Floris D. de, Saskia B. Ebeling, Joachim Grötzinger, et al.. (1995). Leucine‐58 in the putative 5th helical region of human interleukin (IL)‐6 is important for activation of the IL‐6 signal transducer, gp130. FEBS Letters. 369(2-3). 187–191. 10 indexed citations
4.
Ehlers, Marc, Joachim Grötzinger, Floris D. de Hon, et al.. (1995). Residues 77‐95 of the Human Interleuken‐6 Protein are Responsible for Receptor Binding and Residues 41‐56 for Signal Transduction. Annals of the New York Academy of Sciences. 762(1). 400–402. 5 indexed citations
5.
Ehlers, Marc, Floris D. de Hon, Ursula Horsten, et al.. (1995). Combining Two Mutations of Human Interleukin-6 That Affect gp130 Activation Results in a Potent Interleukin-6 Receptor Antagonist on Human Myeloma Cells. Journal of Biological Chemistry. 270(14). 8158–8163. 41 indexed citations
6.
Hon, Floris D. de, Marc Ehlers, Stefan Rose‐John, et al.. (1994). Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.. The Journal of Experimental Medicine. 180(6). 2395–2400. 45 indexed citations
7.
Brakenhoff, Just P. J., Floris D. de Hon, Marc Ehlers, et al.. (1994). An IL-6 receptor antagonist for IL-6 activity on human myeloma cells. Cytokine. 6(5). 564–564. 1 indexed citations
8.
Brakenhoff, Just P. J., Floris D. de Hon, Véronique Fontaine, et al.. (1994). Development of a human interleukin-6 receptor antagonist.. Journal of Biological Chemistry. 269(1). 86–93. 99 indexed citations
9.
Gaag, Ruth van der, et al.. (1991). Indomethacin increases the sensitivity of the monocyte migration inhibition assay. Journal of Immunological Methods. 136(1). 69–76. 1 indexed citations
10.
Murray, Philip I., et al.. (1990). Aqueous humor interleukin-6 levels in uveitis.. PubMed. 31(5). 917–20. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026